The abrdn World Healthcare Fund (THW) remains attractive for income investors with a 10.4% yield and trading at a 1.98% discount to NAV. Its portfolio focuses on biotechnology and pharmaceuticals, benefiting from GLP-1 market growth and AI-driven healthcare innovation. However, distributions come from net realized gains rather than net investment income, which could erode NAV during loss periods. While monthly payouts suit income-focused investors, capital appreciation is limited and high interest rates may pressure earnings going forward.
In June 2026, Amazon Prime Day and Walmart Deals overlapped for the first time, attracting 64% of U.S. consumers to shop at least one event, up from 33% in 2025. This overlap brought millions of new shoppers, especially baby boomers and seniors, who ...
Airbus and Boeing are both recovering well in jet deliveries, nearing pre-pandemic output levels with a 12% year-over-year increase. Airbus leads the 2026 order race with 1,024 net orders compared to Boeing's 438, holding a $23.1 billion advantage in...
Ferrexpo PLC's shares surged 29% to 36.88p after restarting iron ore production at its Ukrainian operations using one pellet line. The restart follows a $100 million fundraising that enabled quick mobilization despite ongoing war-related disruptions....
Ashmore Group's shares recovered after an initial drop as investors balanced a 17% rise in pre-tax profit and a 28% increase in earnings per share against weaker underlying financial results. Despite a 13% growth in assets under management to $54 bil...
The 4-Factor Dividend Growth Strategy, inspired by the Schwab US Dividend Equity ETF (SCHD), targets high-quality dividend stocks using four key metrics. Since its inception, it has delivered an average return of 14.89%, marginally beating SCHD's 14....
